348 related articles for article (PubMed ID: 16638096)
1. Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations.
Taguchi A; Ohmiya N; Itoh A; Hirooka Y; Niwa Y; Mori N; Goto H
J Gastroenterol Hepatol; 2006 Mar; 21(3):545-51. PubMed ID: 16638096
[TBL] [Abstract][Full Text] [Related]
2. Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes.
Oguri A; Ohmiya N; Taguchi A; Itoh A; Hirooka Y; Niwa Y; Maeda O; Ando T; Goto H
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):561-6. PubMed ID: 17556902
[TBL] [Abstract][Full Text] [Related]
3. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
4. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
[TBL] [Abstract][Full Text] [Related]
5. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
6. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis.
Teh M; Tan KB; Seet BL; Yeoh KG
Cancer; 2002 Aug; 95(3):499-505. PubMed ID: 12209741
[TBL] [Abstract][Full Text] [Related]
7. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
8. [Helicobacter pylori and the development of atrophic gastritis].
Takahashi S; Igarashi H; Masubuchi N; Ishiyama N; Saito S; Aoyagi T; Itoh T; Hirata I
Nihon Rinsho; 1993 Dec; 51(12):3231-5. PubMed ID: 8283639
[TBL] [Abstract][Full Text] [Related]
9. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis.
Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G
J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection is the major risk factor for atrophic gastritis.
Kawaguchi H; Haruma K; Komoto K; Yoshihara M; Sumii K; Kajiyama G
Am J Gastroenterol; 1996 May; 91(5):959-62. PubMed ID: 8633588
[TBL] [Abstract][Full Text] [Related]
11. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
13. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
14. p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection.
Marinone C; Martinetti A; Mestriner M; Seregni E; Geuna M; Ferrari L; Strola G; Bonardi L; Fea E; Bombardieri E
Anticancer Res; 2001; 21(2A):1115-8. PubMed ID: 11396149
[TBL] [Abstract][Full Text] [Related]
15. [Interaction between an insertion/deletion polymorphism in pepsinogen C and Helicobacter pylori infection in the development of gastric cancer].
Sun LP; Zhang Y; Liu YE; Chen W; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):644-8. PubMed ID: 19173902
[TBL] [Abstract][Full Text] [Related]
16. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
17. [The conditions of Helicobacter pylori colonization in different gastric diseases].
Liu YE; Yu XW; Dong NN; Gong YH; Sun LP; Yuan Y
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):230-2. PubMed ID: 18361831
[TBL] [Abstract][Full Text] [Related]
18. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis.
Ito M; Haruma K; Kaya S; Kamada T; Kim S; Sasaki A; Sumii M; Tanaka S; Yoshihara M; Chayama K
Scand J Gastroenterol; 2002 Mar; 37(3):287-93. PubMed ID: 11916190
[TBL] [Abstract][Full Text] [Related]
19. [Significance of serum level of NO and IL-8 in Helicobacter pylori associated gastric diseases].
Song CF; Sun LP; Dai WY; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):258-60. PubMed ID: 12839689
[TBL] [Abstract][Full Text] [Related]
20. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
